English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 13 June 2023, 22:00 HKT/SGT
Share:
    

Source: Proventus Bioscience
Proventus Bioscience Breaks Ground on Its New Production Facility and Expansion of Its Laboratories and Fermentation Plant
Proventus Bioscience continues to be a leading innovator and producer of bio-based products that improve crop yields, shorten growing periods, and create healthier, more resilient soils for organic farmers, greenhouse growers and mainstream production farmers. Its impact has been recognized globally.

MONTREAL, QUEBEC, June 13, 2023 - (ACN Newswire) - Proventus Bioscience, a biotech company that produces sustainable biological microorganisms for use by various industries, announced the start of construction of its new 20,000-square-foot production plant and corporate headquarters at 4455 Griffith St., Saint-Laurent, QC.

Proventus' new 20,000-square foot facility is designed to be compliant with current Good Manufacturing Practices (camps) required by the food industry that include bio-infused products for probiotics, agriculture formulations, and treatments for waste management and pollution control. GMP was first developed by the World Health Organization in 1968 and has since evolved and expanded, with 100 countries adopting the provisions in their own requirements.

Speaking at the company's official announcement, the founders of Proventus, Mr. Vincent Delorenzo and Peter Bozel, commented on the company's incredible growth over the last seven years as proof that the company's technology is widely accepted by the industry. The demand for Proventus' products is what propelled this incredible expansion:

"The inauguration of this facility will take place sometime in August and will give Proventus a launching pad from [which to] introduce novel first-in-class sustainable microbial formulations that can be used for a wide spectrum of industries and add many new novel products such as biostimulants and bio-protectants for use in agriculture and remediation of polluted soils.

"Our plans and pipeline for new products are ambitious but attainable because our technology solution is unique in the remediation of polluted waters and soils and for enhancement of biorational agricultural production practices by developing biologicals as compliments or replacement for chemical fertilizers and plant protectants. Its efficacy is being [proven daily] in farmers' fields and in tests conducted in laboratories and greenhouses at respected research institutions throughout Canada.

"Proventus' core technology is in constant development. We have acquired the most up-to-date fermentation equipment, solid-state fermenters, high-capacity freeze dryers and methods to formulate and stabilize viruses, bacteria, and fungi for optimal activity under all environmental conditions."

Internationally recognized plant scientist Dr. George Lazarovits heads the Proventus Scientific Advisory Board.

Visit proventusbioscience.com or call 438-387-1117 for more information.

About Proventus Bioscience Inc.

Proventus Bioscience Inc., based in Montreal, is a biotech company that develops sustainable biological products for the management of polluted environments and for use in sustainable agriculture. It has pioneered many other products with eco-positive solutions and continues to develop new innovations as a response to market changes on its own as well as with major partnerships.

Acknowledgment:

Proventus Bioscience would like to take this opportunity to thank the Economic Development Agency of Canada for the Regions of Quebec for its financial support. REGI is a national funding program that supports the economic growth of businesses and regions through innovation.

Contact Information
Vincent DeLorenzo
Founding Member
info@proventusbioscience.com

Topic: Press release summary
Source: Proventus Bioscience

Sectors: BioTech, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Q2 Metals Announces Re-Assay Results and Spring 2024 Exploration Plan for Cisco Lithium Property, James Bay Territory, Quebec, Canada  
May 16, 2024 15:09 HKT/SGT
Rover Announces and Closes $0.03 Unit Financing  
May 16, 2024 05:00 HKT/SGT
New Research Increases Confidence in the Benefits of Vegan Diets for Dogs  
May 16, 2024 05:00 HKT/SGT
3rd Annual Clean Power & New Energy 2024  
May 15, 2024 21:53 HKT/SGT
Dubai FinTech Summit concludes with over 8,000 visitors from 118 countries  
May 15, 2024 21:40 HKT/SGT
Honda and IBM sign Memorandum of Understanding to Explore Long-term Joint Research and Development of Semiconductor Chip and Software Technologies for Future Software-Defined Vehicles  
Wednesday, May 15, 2024 1:30:00 PM
Intermodal Terminal Company (ITC) Chooses Hexagon to Deliver Groundbreaking Australian Rail Terminal  
May 15, 2024 12:32 HKT/SGT
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status  
Wednesday, May 15, 2024 10:19:00 AM
Five Tips to build Personalised Engagement with your Customers  
May 15, 2024 09:05 HKT/SGT
Former Microsoft, IBM and Compaq Executive to Head APJ Expansion for GTDC  
May 15, 2024 09:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575